STX-0119
≥99%
- Product Code: 237405
CAS:
851095-32-4
| Molecular Weight: | 382.37 g./mol | Molecular Formula: | C₂₂H₁₄N₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
STX-0119 is primarily investigated for its potential in cancer therapy, specifically targeting hematological malignancies such as lymphoma and leukemia. It functions as a STAT3 (Signal Transducer and Activator of Transcription 3) inhibitor, disrupting the signaling pathway that promotes tumor cell survival, proliferation, and immune evasion. By inhibiting STAT3 activation, STX-0119 induces apoptosis in cancer cells and reduces tumor growth in preclinical models. Its application is particularly relevant in cancers where STAT3 is constitutively active, offering a targeted approach with potential for improved selectivity and reduced off-target effects compared to conventional chemotherapy. Research is ongoing to evaluate its efficacy alone and in combination with other anti-cancer agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿5,590.00 |
+
-
|
| 10mg | 10-20 days | ฿17,110.00 |
+
-
|
| 5mg | 10-20 days | ฿10,150.00 |
+
-
|
STX-0119
STX-0119 is primarily investigated for its potential in cancer therapy, specifically targeting hematological malignancies such as lymphoma and leukemia. It functions as a STAT3 (Signal Transducer and Activator of Transcription 3) inhibitor, disrupting the signaling pathway that promotes tumor cell survival, proliferation, and immune evasion. By inhibiting STAT3 activation, STX-0119 induces apoptosis in cancer cells and reduces tumor growth in preclinical models. Its application is particularly relevant in cancers where STAT3 is constitutively active, offering a targeted approach with potential for improved selectivity and reduced off-target effects compared to conventional chemotherapy. Research is ongoing to evaluate its efficacy alone and in combination with other anti-cancer agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :